Apotex Bid To Overturn Prilosec Decision Denied
A District of Columbia judge has refused to overturn a federal agency decision that blocked drug manufacturer Apotex Corp. from marketing a generic version of gastric-acid-inhibiting drug Prilosec because it infringed...To view the full article, register now.
Already a subscriber? Click here to view full article